1 Urine in clinical proteomics
暂无分享,去创建一个
Harald | B. Monsarrat | J. Schanstra | S. Decramer | J. Bascands | B. Breuil | A. G. Peredo | Mischak
[1] X. Brannmjk. Capillary , 2020, Definitions.
[2] Zhengyu Jin,et al. Current applications and challenges of radiomics in urothelial cancer , 2019, Chinese Journal of Academic Radiology.
[3] A. Vlahou,et al. Establishment of a European Network for Urine and Kidney Proteomics. , 2008, Journal of proteomics.
[4] A. Dominiczak,et al. CE‐MS analysis of the human urinary proteome for biomarker discovery and disease diagnostics , 2008, Proteomics. Clinical applications.
[5] D. Maahs,et al. The urinary proteome in diabetes and diabetes‐associated complications: New ways to assess disease progression and evaluate therapy , 2008, Proteomics. Clinical applications.
[6] V. Thongboonkerd,et al. Towards Standard Protocols and Guidelines for Urine Proteomics: A Report on the Human Kidney and Urine Proteome Project (HKUPP) Symposium and Workshop 6 October 2007, Seoul, Korea and 1 November 2007, San Francisco, CA, USA , 2008, Proteomics.
[7] H. Mischak,et al. Discovery and validation of urinary biomarkers for prostate cancer , 2008, Proteomics. Clinical applications.
[8] Lennart Martens,et al. Analysis of the experimental detection of central nervous system‐related genes in human brain and cerebrospinal fluid datasets , 2008, Proteomics.
[9] Walter Kolch,et al. Urinary Proteomic Biomarkers in Coronary Artery Disease*S , 2008, Molecular & Cellular Proteomics.
[10] A. Vlahou,et al. Challenges of using mass spectrometry as a bladder cancer biomarker discovery platform , 2008, World Journal of Urology.
[11] S. Carr,et al. Quantitative, Multiplexed Assays for Low Abundance Proteins in Plasma by Targeted Mass Spectrometry and Stable Isotope Dilution*S , 2007, Molecular & Cellular Proteomics.
[12] B. Monsarrat,et al. The invisible proteome: how to capture the low abundance proteins via combinatorial ligand libraries , 2007 .
[13] A. Dominiczak,et al. Body fluid proteomics for biomarker discovery: lessons from the past hold the key to success in the future. , 2007, Journal of proteome research.
[14] V. Thongboonkerd,et al. Bacterial overgrowth affects urinary proteome analysis: recommendation for centrifugation, temperature, duration, and the use of preservatives during sample collection. , 2007, Journal of proteome research.
[15] P. Righetti,et al. Exploring the platelet proteome via combinatorial, hexapeptide ligand libraries. , 2007, Journal of proteome research.
[16] F. Algaba,et al. Searching urinary tumor markers for bladder cancer using a two-dimensional differential gel electrophoresis (2D-DIGE) approach. , 2007, Journal of proteome research.
[17] Juri Rappsilber,et al. Proteomic analysis of human blood serum using peptide library beads. , 2007, Journal of proteome research.
[18] Visith Thongboonkerd,et al. Practical points in urinary proteomics. , 2007, Journal of proteome research.
[19] W. Gwinner,et al. Renal transplant rejection markers , 2007, World Journal of Urology.
[20] J. Schanstra,et al. Non-invasive markers of ureteropelvic junction obstruction , 2007, World Journal of Urology.
[21] V. Thongboonkerd. Recent progress in urinary proteomics , 2007, Proteomics. Clinical applications.
[22] Denis Hochstrasser,et al. How shall we use the proteomics toolbox for biomarker discovery? , 2007, Journal of proteome research.
[23] K. Rossing. Progression and remission of nephropathy in type 2 diabetes: new strategies of treatment and monitoring. , 2007, Danish medical bulletin.
[24] Harald Mischak,et al. Advances in urinary proteome analysis and biomarker discovery. , 2007, Journal of the American Society of Nephrology : JASN.
[25] M. Goligorsky,et al. Characterization of Urinary Peptide Biomarkers of Acute Rejection in Renal Allografts , 2007, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[26] S. Baumann,et al. Standardized peptidome profiling of human urine by magnetic bead separation and matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. , 2007, Clinical chemistry.
[27] M. Girolami,et al. Clinical proteomics: A need to define the field and to begin to set adequate standards , 2007, Proteomics. Clinical applications.
[28] O. Nemirovskiy,et al. Discovery and development of a type II collagen neoepitope (TIINE) biomarker for matrix metalloproteinase activity: from in vitro to in vivo. , 2007, Analytical biochemistry.
[29] Lennart Martens,et al. Annotating the human proteome: beyond establishing a parts list. , 2007, Biochimica et biophysica acta.
[30] Terence C W Poon,et al. Opportunities and limitations of SELDI-TOF-MS in biomedical research: practical advices , 2007, Expert review of proteomics.
[31] F. Scolari,et al. Repetitive Fragmentation Products of Albumin and α1-Antitrypsin in Glomerular Diseases Associated with Nephrotic Syndrome , 2006 .
[32] Richard D. Smith,et al. Advances and Challenges in Liquid Chromatography-Mass Spectrometry-based Proteomics Profiling for Clinical Applications* , 2006, Molecular & Cellular Proteomics.
[33] Ruedi Aebersold,et al. Challenges and Opportunities in Proteomics Data Analysis* , 2006, Molecular & Cellular Proteomics.
[34] H. Mischak,et al. High resolution proteome/peptidome analysis of body fluids by capillary electrophoresis coupled with MS , 2006, Proteomics.
[35] M. Mann,et al. The human urinary proteome contains more than 1500 proteins, including a large proportion of membrane proteins , 2006, Genome Biology.
[36] Steven A Carr,et al. Protein biomarker discovery and validation: the long and uncertain path to clinical utility , 2006, Nature Biotechnology.
[37] E. Hoorn,et al. The Application of DIGE-Based Proteomics to Renal Physiology , 2006, Nephron Physiology.
[38] M. Mann,et al. Status of complete proteome analysis by mass spectrometry: SILAC labeled yeast as a model system , 2006, Genome Biology.
[39] H. Mischak,et al. Biomarker discovery by CE‐MS enables sequence analysis via MS/MS with platform‐independent separation , 2006, Electrophoresis.
[40] Michael Liebman,et al. Proteomic profiling of human urine using multi-dimensional protein identification technology. , 2006, Journal of chromatography. A.
[41] J. Dear,et al. Collection, storage, preservation, and normalization of human urinary exosomes for biomarker discovery. , 2006, Kidney international.
[42] H. Mischak,et al. Predicting the clinical outcome of congenital unilateral ureteropelvic junction obstruction in newborn by urinary proteome analysis , 2006, Nature Medicine.
[43] V. Thulasiraman,et al. Reducing protein concentration range of biological samples using solid-phase ligand libraries. , 2006, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.
[44] H. Frierson,et al. Discovery and validation of new protein biomarkers for urothelial cancer: a prospective analysis. , 2006, The Lancet. Oncology.
[45] Wei Sun,et al. Concanavalin A-captured Glycoproteins in Healthy Human Urine *S , 2006, Molecular & Cellular Proteomics.
[46] Jue Wang,et al. Human urine proteome analysis by three separation approaches , 2005, Proteomics.
[47] H. Huland,et al. Stage‐dependent increase of orosomucoid and zinc‐alpha2‐glycoprotein in urinary bladder cancer , 2005, Proteomics.
[48] W. Kolch,et al. Capillary electrophoresis-mass spectrometry as a powerful tool in clinical diagnosis and biomarker discovery. , 2005, Mass spectrometry reviews.
[49] K. Oofusa,et al. Proteome analysis of gelatin-bound urinary proteins from patients with bladder cancers. , 2005, European urology.
[50] M. J. Chalmers,et al. Combined top-down and bottom-up mass spectrometric approach to characterization of biomarkers for renal disease. , 2005, Analytical chemistry.
[51] Juri Rappsilber,et al. Exploring the hidden human urinary proteome via ligand library beads. , 2005, Journal of proteome research.
[52] H. Mischak,et al. Detection of Acute Tubulointerstitial Rejection by Proteomic Analysis of Urinary Samples in Renal Transplant Recipients , 2005, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[53] Ronald J Moore,et al. Characterization of the human blood plasma proteome , 2005, Proteomics.
[54] A. Ganser,et al. Online coupling of capillary electrophoresis with mass spectrometry for the identification of biomarkers for clinical diagnosis , 2005, Expert review of proteomics.
[55] Liliana Gheorghiu,et al. Reduction of the concentration difference of proteins in biological liquids using a library of combinatorial ligands , 2005, Electrophoresis.
[56] Eugene A. Kapp,et al. Overview of the HUPO Plasma Proteome Project: Results from the pilot phase with 35 collaborating laboratories and multiple analytical groups, generating a core dataset of 3020 proteins and a publicly‐available database , 2005, Proteomics.
[57] Harald Mischak,et al. Capillary electrophoresis coupled to mass spectrometry for clinical diagnostic purposes , 2005, Electrophoresis.
[58] H. Mischak,et al. Identification of urinary protein pattern in type 1 diabetic adolescents with early diabetic nephropathy by a novel combined proteome analysis. , 2005, Journal of diabetes and its complications.
[59] A. Semjonow,et al. Pilot study of capillary electrophoresis coupled to mass spectrometry as a tool to define potential prostate cancer biomarkers in urine , 2005, Electrophoresis.
[60] H. Parving,et al. Impact of diabetic nephropathy and angiotensin II receptor blockade on urinary polypeptide patterns. , 2005, Kidney international.
[61] H. Mischak,et al. Urine protein patterns can serve as diagnostic tools in patients with IgA nephropathy. , 2005, Kidney international.
[62] Walter Kolch,et al. Discovery of biomarkers in human urine and cerebrospinal fluid by capillary electrophoresis coupled to mass spectrometry: Towards new diagnostic and therapeutic approaches , 2005, Electrophoresis.
[63] J. Listgarten,et al. Statistical and Computational Methods for Comparative Proteomic Profiling Using Liquid Chromatography-Tandem Mass Spectrometry , 2005, Molecular & Cellular Proteomics.
[64] Visith Thongboonkerd,et al. Renal and urinary proteomics: Current applications and challenges , 2005, Proteomics.
[65] A. Bello,et al. Chronic kidney disease: the global challenge , 2005, The Lancet.
[66] M. Kretzler,et al. Bioinformatic analysis of the urine proteome of acute allograft rejection. , 2004, Journal of the American Society of Nephrology : JASN.
[67] Thorsten Kaiser,et al. Proteomic analysis for the assessment of diabetic renal damage in humans. , 2004, Clinical science.
[68] Ian M Thompson,et al. Prostate‐specific antigen: A review of the validation of the most commonly used cancer biomarker , 2004, Cancer.
[69] A. Ganser,et al. Proteomics applied to the clinical follow-up of patients after allogeneic hematopoietic stem cell transplantation. , 2004, Blood.
[70] L. Greenbaum,et al. Upper urinary tract: when is obstruction obstruction? , 2004, Current opinion in urology.
[71] Erika Check,et al. Proteomics and cancer: Running before we can walk? , 2004, Nature.
[72] H. Mischak,et al. Proteomic patterns established with capillary electrophoresis and mass spectrometry for diagnostic purposes. , 2004, Kidney international.
[73] J. Neilson,et al. Calcineurin is required in urinary tract mesenchyme for the development of the pyeloureteral peristaltic machinery. , 2004, The Journal of clinical investigation.
[74] Rembert Pieper,et al. Characterization of the human urinary proteome: A method for high‐resolution display of urinary proteins on two‐dimensional electrophoresis gels with a yield of nearly 1400 distinct protein spots , 2004, Proteomics.
[75] Richard D. Smith,et al. FTICR mass spectrometry for qualitative and quantitative bioanalyses. , 2004, Current opinion in biotechnology.
[76] W. Kolch,et al. Mass spectrometry for the detection of differentially expressed proteins: a comparison of surface-enhanced laser desorption/ionization and capillary electrophoresis/mass spectrometry. , 2004, Rapid communications in mass spectrometry : RCM.
[77] P. Selby,et al. Proteomic profiling of urinary proteins in renal cancer by surface enhanced laser desorption ionization and neural-network analysis: identification of key issues affecting potential clinical utility. , 2003, Cancer research.
[78] D. Chan,et al. Characterization of Renal Allograft Rejection by Urinary Proteomic Analysis , 2003, Annals of surgery.
[79] Yoav Benjamini,et al. Identifying differentially expressed genes using false discovery rate controlling procedures , 2003, Bioinform..
[80] N. Anderson,et al. The Human Plasma Proteome , 2002, Molecular & Cellular Proteomics.
[81] A. Nerlich,et al. Matrix metalloproteinases (MMPs) in breast cancer cell lines of different tumorigenicity. , 2001, Anticancer research.
[82] R. Wahl,et al. Towards defining the urinary proteome using liquid chromatography‐tandem mass spectrometry I.Profiling an unfractionated tryptic digest , 2001, Proteomics.
[83] L. Iorio,et al. Observations on the Liber medicine orinalibus by Hermogenes , 1999, American Journal of Nephrology.
[84] B. Honoré,et al. Bladder squamous cell carcinomas express psoriasin and externalize it to the urine. , 1996, The Journal of urology.
[85] C. E. Mogensen,et al. Systemic blood pressure and glomerular leakage with particular reference to diabetes and hypertension , 1994, Journal of internal medicine.
[86] Y. Chaubey. Resampling-Based Multiple Testing: Examples and Methods for p-Value Adjustment , 1993 .
[87] P. Vestergaard,et al. Constancy of urinary creatinine excretion. , 1958, The Journal of laboratory and clinical medicine.
[88] A. Vlahou,et al. Urine sample preparation and protein profiling by two-dimensional electrophoresis and matrix-assisted laser desorption ionization time of flight mass spectroscopy. , 2008, Methods in molecular biology.
[89] Thomas Deufel,et al. Use of SELDI-TOF mass spectrometry for identification of new biomarkers: potential and limitations. , 2007, Clinical chemistry and laboratory medicine.
[90] Christian W Klampfl,et al. Recent advances in the application of capillary electrophoresis with mass spectrometric detection , 2006, Electrophoresis.
[91] P. Nickerson,et al. Proteomic-based detection of urine proteins associated with acute renal allograft rejection. , 2004, Journal of the American Society of Nephrology : JASN.
[92] P. Nickerson,et al. Urine protein profiling with surface-enhanced laser-desorption/ionization time-of-flight mass spectrometry. , 2004, Kidney international.
[93] Y. Benjamini,et al. Controlling the false discovery rate: a practical and powerful approach to multiple testing , 1995 .